Abstract
The paper discusses the evolution and growth of Indian biotech companies in recent years. It focuses on the alternative business models key players in the industry have adopted and highlights the activities and achievements of some of the globally competitive companies across various segments of the market. The paper also chronicles recent developments in the industry with respect to international alliances, product development and investment and expansion. Increasingly, India is being recognised as a country that combines low-cost research and manufacturing capabilities with a rapidly improving climate for intellectual property (IP) creation and protection. Efforts are being made by Indian companies to move up the value chain in niche areas within the biotechnology sector. There is indeed a clear opportunity for global players to leverage the India advantage by collaborating with Indian companies and exploring potential market opportunities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have